Neuronal Nitric Oxide Synthase Regulates Depression-like Behaviors in Shortening-Induced Obese Mice
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Shortening is mainly derived from the partial hydrogenation of palm oil and widely used in fast food. Food processed with shortening contains high levels of industrial trans fatty acids. Studies have shown that there is a correlation between industrial trans fatty acids, obesity, and depression. However, the regulatory effect of neuronal nitric oxide synthase (nNOS) on depression in obese patients is still unknown. The purpose of this study was to explore mood changes in obese mice fed a high shortening diet, and to determine the regulatory effect of nNOS on depressive-like behaviors in obese mice. We used a high shortening diet-induced obesity mouse model to systematically assess the metabolic response, behavioral changes, prefrontal and hippocampal nNOS protein levels, and the effect of nNOS inhibitors (7-nitroindole) on depression-like behavior in obese mice. Interestingly, obese mice on a 9-week high-shortening diet developed short-term spatial working memory impairment and anxiety-like behavior, and obesity may be a risk factor for cognitive impairment and mood disorders. In animals fed a high shortening diet for 12 weeks, obese mice developed depression-like behavior and had significantly elevated levels of nNOS protein expression in the hippocampus and prefrontal lobe. Administration of the nNOS inhibitor 7-nitroindole could improve depression-like behaviors in obese mice, further suggesting that inhibition of nNOS is helpful for depression associated with obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Preclinical work supports that administration of nNOS inhibitors, such as 7-nitroindole, reduces depressive-like behaviors in obese mice (124).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110 · cited 1×
“7-NI is a fast and reversible nNOS inhibitor, which competitively binds to the tetrahydrobiopterin (nNOS cofactor) sight, leading to inactivation of the nNOS dimer and inhibition of NO production [46].”
BackgroundBehavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,063
Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Piché, M.-E., Tchernof, A., & Després, J.-P. (2020) · Circulation Research · doi:10.1161/circresaha.120.316101 · Cited by 1,986 · cited 1×
“The advent of the fast food era has greatly contributed to the global prevalence of obesity [1].”
BackgroundThe brain reward circuitry in mood disorders
Russo, S. J., & Nestler, E. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3381 · Cited by 1,870 · cited 1×
“Anxiety and depression can increase food cravings that can lead to a deleterious cycle that can increase the risk of obesity and emotional disorder comorbidities [16,17].”
BackgroundNitric oxide, a novel neuronal messenger
Bredt, D. S., & Snyder, S. H. (1992) · Neuron · doi:10.1016/0896-6273(92)90104-l · Cited by 1,846 · cited 1×
“In the central nervous system, NO is both a neurotransmitter and a neuromodulator, playing an important role in synaptic and intercellular information transmission [20].”
BackgroundMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 1×
“Studies have shown that after industrial trans fatty intake, plasma levels of total cholesterol and low-density lipoproteins increase, whereas high-density lipoprotein levels decrease, and this increases the risk of obesity and metabolic diseases [5,6].”
BackgroundDepression and obesity: evidence of shared biological mechanisms
Milaneschi, Y., Simmons, W. K., van Rossum, E. F. C., & Penninx, B. W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0017-5 · Cited by 1,073 · cited 2×
“Multiple biological pathways are involved in the depression-obesity link, including genetics, HPA axis abnormalities, immuno-inflammatory activation, alterations in neuroendocrine regulators of energy metabolism and brain circuitries integrating mood regulatory responses [19].”
BackgroundWinzell, M. S., & Ahrén, B. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s215 · Cited by 1,026 · cited 1×
“As obesity models, C57BL/6J mice are prone to show characteristics of obesity when they are fed a high-fat diet [34].”
Background
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Preclinical work supports that administration of nNOS inhibitors, such as 7-nitroindole, reduces depressive-like behaviors in obese mice (124).”
Rodkin, S., Nwosu, C., Sannikov, A., Tyurin, A. V., Чулков, В. С., Raevskaya, M., Ermakov, A. M., Kirichenko, E. Y., & Гасанов, М. З. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076014 · Cited by 44
Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences
Singh, P., Vasundhara, B., Das, N., Sharma, R., Kumar, A., & Datusalia, A. K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04302-5 · Cited by 21
Poon, E., Li, C., Schweitzer, D. R., & Akefe, I. O. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1754492 · Cited by 17
“…with high levels of AGEs, and AGEs have a strong association with MDD and a higher mortality risk of MDD. Shortening (part of the Maillard reaction) increases neuronal nitric oxide synthase (nNOS) activity, which can lead to excessive signaling, reactive nitrogen species, and cell toxicity (97).”
Vega‐Rivera, N. M., Estrada-Camarena, E. M., Azpilcueta-Morales, G., Cervantes-Anaya, N., Treviño, S., Becerril‐Villanueva, E., & López‐Rubalcava, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031455 · Cited by 5
Cerebrolysin Ameliorates Age-Induced Dendritic Spine Degeneration and Memory Decline in C57BL6 Mice
Aguilar‐Hernández, L., Flores‐Gómez, G. D., Nácher, J., Morales‐Medina, J. C., & Flores, G. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04627-0 · Cited by 3
Mata-Bermúdez, A., Trejo-Chávez, R., Martínez-Vargas, M., Pérez-Arredondo, A., Díaz-Ruiz, A., Ríos, C., Romero-Sánchez, H. A., Martínez-Cárdenas, M. D. L. Á., Ugalde‐Muñiz, P., Noriega‐Navarro, R., et al. (2025) · NeuroSci · doi:10.3390/neurosci6040092 · Cited by 2
“A recent study reported that depressive behaviors are associated with an increase in NO levels in obese mice [13]; in addition, glutamatergic modulators, including N-methyl-D-aspartate (NMDA) receptor antagonists, are known to exhibit similar effects on NO levels to those observed with…”
Brain Health in Metabolic Disease and Exercise
Tomiga, Y. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815313925124010006
The NO-cGMP signaling pathway and depression: mechanisms and therapeutic prospects
Wenling, P., Yuting, S. U. N., Dai, X., Huo, Q., Zuo, Z., Xie, F., & Sun, Y. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12593-1
Mechanistic link of obesity to depression and cognitive decline in Alzheimer’s disease
Kusi‐Mensah, K., Jones, N., Haroon, H., Veldić, M., & Choi, D. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106979
Depression and Heart Failure With Preserved Ejection Fraction: An Inflammatory Perspective
Chen, H., Zhang, N., Feng, Y., Tao, M., & Geng, C. (2026) · Depression and Anxiety · doi:10.1155/da/7169650
“Endothelial dysfunction under in fl am-matory conditions promotes HFpEF via multiple mechanisms, such as nitric oxide (NO) dysregulation and endothelial cell secretory dysfunction [84], which are also closely related to depression and exert bidirectional in fl uences [85 – 87].”
Metadata
- Authors
- Wang, P., Kong, F.-Z., Hong, X.-H., Zhang, L., Zhao, W.-H., Yang, J.-C., & Zhang, H.
- Affiliations
- Shantou University (CN)
- Corresponding author
- Zhang, Heng
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-10-14
- Volume
- 14
- Issue
- 20
- Pages
- 4302
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC9609729
- OpenAlex
- W4306399061
- Cited by
- 11
- References
- 58
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 2
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Science and Technology Special Fund Project of Guangdong (2019ST031, B2017020)
- Medical Scientific Research Foundation of Guangdong, China (2019ST031, B2017020)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- neuronal nitric oxide synthase, depression-like behavior, trans fatty acids, nNOS inhibitors, hippocampus, prefrontal cortex, anxiety-like behavior, mood disorders, cognitive impairment
- MeSH terms
- Palm Oil, Animals, Depression, Hippocampus, Mice, Obese, Nitric Oxide, Obesity, Trans Fatty Acids, Mice, Nitric Oxide Synthase Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.